Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk
- PMID: 23496028
- DOI: 10.1089/met.2013.1503
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk
Comment on
-
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.Metab Syndr Relat Disord. 2013 Jun;11(3):152-6. doi: 10.1089/met.2012.0103. Epub 2012 Nov 21. Metab Syndr Relat Disord. 2013. PMID: 23170931 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical